• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Cencora

    Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Supports Pharmaceutical Supply Chain Education with Two New Programs for Health System Pharmacy Residents
    From Cencora
    Via Business Wire
    Cencora Elects Frank Clyburn to Its Board of Directors
    From Cencora
    Via Business Wire
    Tickers COR
    Alcura Obtains Manufacturing and Importation Authorization License, Expanding its Capabilities to Support Cell & Gene Therapy Developers
    From Cencora
    Via Business Wire
    Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
    From Cencora
    Via Business Wire
    Tickers COR
    Good Neighbor Pharmacy® Named #1 in Customer Satisfaction with Chain Drug Store Pharmacies by J.D. Power for 8th Consecutive Year
    From Cencora
    Via Business Wire
    Cencora Reports Fiscal 2024 Third Quarter Results
    From Cencora
    Via Business Wire
    Tickers COR
    Good Neighbor Pharmacy Network Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2024
    From Cencora
    Via Business Wire
    Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit
    From Cencora
    Via Business Wire
    Cencora Reports Fiscal 2024 Second Quarter Results
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Announces Leadership Succession Plan
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products
    From Cencora
    Via Business Wire
    Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Closes $500 Million Senior Notes Offering
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Releases 2023 ESG Report
    From Cencora
    Via Business Wire
    Cencora Prices $500 Million 5.125% Senior Notes Due 2034
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Reports Fiscal 2024 First Quarter Results
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
    From Cencora
    Via Business Wire
    Tickers COR
    World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
    From Cencora
    Via Business Wire
    Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
    From Cencora
    Via Business Wire
    Tickers COR
    Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
    From Cencora
    Via Business Wire
    Tickers COR
    MWI Animal Health Completes Integration with Shepherd Veterinary Software
    From Cencora
    Via Business Wire
    Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release
    From Cencora
    Via Business Wire
    Tickers COR
    AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care
    From Cencora
    Via Business Wire
    Tickers COR
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.